105 related articles for article (PubMed ID: 10155115)
1. Coronary stenting: costly or cost-effective?
Cohen DJ; Baim DS
J Invasive Cardiol; 1995; 7 Suppl A():36A-42A. PubMed ID: 10155115
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
[TBL] [Abstract][Full Text] [Related]
4. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan.
Ikeda S; Bosch J; Banz K; Schneller P
J Invasive Cardiol; 2000 Apr; 12(4):194-9. PubMed ID: 10785672
[TBL] [Abstract][Full Text] [Related]
5. Medical economic considerations of coronary stenting.
Szucs TD
Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
[TBL] [Abstract][Full Text] [Related]
6. [Intracoronary prosthesis (stent): an approach to the analysis of cost-effectiveness].
Iñíguez Romo A
Rev Esp Cardiol; 1997; 50 Suppl 2():83-94. PubMed ID: 9221460
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.
Cohen DJ; Breall JA; Ho KK; Kuntz RE; Goldman L; Baim DS; Weinstein MC
Circulation; 1994 Apr; 89(4):1859-74. PubMed ID: 8149551
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of minimally invasive cardiac operations.
Ferraris VA; Ferraris SP
Heart Surg Forum; 2001; 4 Suppl 1():S30-4. PubMed ID: 11178305
[TBL] [Abstract][Full Text] [Related]
10. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
Cohen DJ; Murphy SA; Baim DS; Lavelle TA; Berezin RH; Cutlip DE; Ho KK; Kuntz RE;
J Am Coll Cardiol; 2004 Nov; 44(9):1801-8. PubMed ID: 15519010
[TBL] [Abstract][Full Text] [Related]
12. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
Chino M; Sakamoto M; Sasaki T; Isshiki T
J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
[TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness of coronary angioplasty procedures in Poland].
Gasior M; Gierlotka M; Gasior U; Chodór P; Lekston A; Klosa Z; Balcarek J; Kalarus Z; Poloński L; Zembala M
Kardiol Pol; 2004 Jul; 61(7):42-7; discussion 48. PubMed ID: 15338017
[TBL] [Abstract][Full Text] [Related]
14. Shifting the balance: direct stenting a novel approach to improve the cost effectiveness of intra-coronary stenting.
Cotton JM; Kearney MT; Wainwright RJ
Eur Heart J; 2000 Jan; 21(2):170. PubMed ID: 10637091
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
[TBL] [Abstract][Full Text] [Related]
16. Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes.
Ijsselmuiden AJ; Tangelder GJ; Cotton JM; Vaijifdar B; Kiemeneij F; Slagboom T; v d Wieken R; Serruys PW; Laarman GJ
Int J Cardiovasc Intervent; 2003; 5(3):143-50. PubMed ID: 12959731
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of stenting with or without balloon predilation for the treatment of coronary artery disease.
Kovar LI; Monrad ES; Sherman W; Kunchithapatham S; Ravi KL; Gotsis W; Silverman G; Brown DL
Am Heart J; 2001 Nov; 142(5):E9. PubMed ID: 11685184
[TBL] [Abstract][Full Text] [Related]
18. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
19. Reducing costs and improving outcomes of percutaneous coronary interventions.
Moscucci M; Muller DW; Watts CM; Bahl V; Bates ER; Werns SW; Kline-Rogers E; Karavite D; Eagle KA
Am J Manag Care; 2003 May; 9(5):365-72. PubMed ID: 12744298
[TBL] [Abstract][Full Text] [Related]
20. The dollars and sense of drug-eluting stents.
Brophy JM
CMAJ; 2005 Feb; 172(3):361-2. PubMed ID: 15684119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
